Skip to main content
. 2022 Jan 27;10(2):204. doi: 10.3390/vaccines10020204

Figure 3.

Figure 3

Impact of HPV DNA ((A) p = 0.64 at Log-Rank) and of p16 expression ((B) IRS ≥ 4 cut-off p = 0.21 at Log-Rank; (C) IRS ≥ 6 cut-off p = 0.97 at Log-Rank) on overall survival. Impact of HPV DNA ((D) p = 0.86 at Log-Rank) and of p16 expression ((E) IRS ≥ 4 cut-off p = 0.013 at Log-Rank; (F) IRS ≥ 6 cut-off p = 0.26 at Log-Rank) on relapse free survival of the overall series.